Pharr Declares October 2025 as National Breast Cancer Awareness Month

Translate to Spanish or other 102 languages!

The proclamation recognizes the importance of early detection, treatment, and continued research in the fight against breast cancer, as well as the courage and strength of survivors.  Image courtesy of The City of Pharr
The proclamation recognizes the importance of early detection, treatment, and continued research in the fight against breast cancer, as well as the courage and strength of survivors.  Image courtesy of The City of Pharr
- Advertisement -

The Pharr City Commission approved a proclamation declaring October 2025 as National Breast Cancer Awareness Month. The proclamation recognizes the importance of early detection, treatment, and continued research in the fight against breast cancer, as well as the courage and strength of survivors. 

It also honors the dedication of healthcare professionals and organizations that advocate for prevention and awareness. In attendance to accept the proclamation were Mario Lizcano, DHR Health’s Administrator of Corporate Affairs, and a member of the oncology staff. “We want to make sure on behalf of our board of managers, over 700 physicians, and 6,700 employees, we thank you for always being a part of this recognition over the years and collaborating with us to host events in support of education for breast cancer awareness,” said Lizcano. 

The City of Pharr proudly supports Breast Cancer Awareness Month and remains committed to promoting education, prevention, and hope for a cure.

- Advertisement -

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

TMA Honors Georgetown Pediatrician for a Career of Distinguished Service 

The Texas Medical Association (TMA) has honored Georgetown pediatrician John W. Hellerstedt, MD, with the 2026 TMA Distinguished Service Award in recognition of his 45 years of exemplary service to patients, public health, and organized medicine.   

FDA Clears Path for Expanded Testosterone Therapy Options for Men

The U.S. Food and Drug Administration is taking an initial step to advance treatment options for men’s health by encouraging sponsors of approved testosterone replacement therapy (TRT) products to contact FDA for information if they are interested in pursuing a potential new indication for low libido in men with idiopathic hypogonadism (without a known cause).

Study Finds Persistent Barriers to Hormone Therapy for Cervical Cancer Patients

Most oncologists say they would prescribe hormone therapy to cervical cancer patients who experience early menopause from radiation treatment, but barriers are keeping many from doing so in practice, according to a new University of Kentucky Markey Cancer Center study published in JAMA Network Open.

STC opens Wellness Center at Health Science Professions Campus

South Texas College recently inaugurated a new Wellness Center at its Health Science Professions Campus in McAllen, giving students, faculty and staff free access to a space designed to support both physical and mental well-being.
- Advertisement -